Literature DB >> 29955854

Iron Deficiency Anemia in Patients Undergoing Extracorporeal Photopheresis for Cutaneous T-Cell Lymphoma.

Kimberly W Sanford1, Jennifer Anderson1, Susan Roseff1, Richard A McPherson1.   

Abstract

OBJECTIVE: To describe the indicidence and severity of iron deficiency anemia (IDA) in patients who have received extracorporeal photopheresis (ECP) treatment of cutaneous T-cell lymphoma (CTCL).
METHODS: We performed a retrospective study during a 9-year period of patients with CTCL who were treated with ECP. ECP was performed with UVAR XTS and CELLEX (Therakos Inc). IDA was defined by a drop in hemoglobin (Hb), mean cell volume (MCV), and increased red blood cell distribution width (RDW).
RESULTS: We identified a total of 36 patients; 1 patient was excluded due to severe anemia. In 35 patients, initial hemoglobin values ranged from 9.8 g per dL to 15.9 g per dL, and patients received 4 to 327 ECP treatments. In all, 28 patients showed decreases in Hb of 0.8 g per dL to 6 g per dL during treatments.
CONCLUSION: Chronic ECP led to IDA in 28 of 35 patients with CTCL. IDA occurs due to blood loss when ECP equipment does not return full blood volume to patients.

Entities:  

Mesh:

Year:  2019        PMID: 29955854     DOI: 10.1093/labmed/lmy034

Source DB:  PubMed          Journal:  Lab Med        ISSN: 0007-5027


  3 in total

Review 1.  The immunopathogenesis and immunotherapy of cutaneous T cell lymphoma: Current and future approaches.

Authors:  David M Weiner; Joseph S Durgin; Maria Wysocka; Alain H Rook
Journal:  J Am Acad Dermatol       Date:  2020-12-22       Impact factor: 11.527

2.  Factors Associated With In-Hospital Mortality in Mycosis Fungoides Patients: A Multivariable Analysis.

Authors:  Amber Loren O King; Victor Lee; Fatima N Mirza; Vikram Jairam; Daniel X Yang; James B Yu; Henry S Park; Michael Girardi; Lynn D Wilson; Yi An
Journal:  Cureus       Date:  2022-08-15

3.  Cutaneous T-cell lymphomas: 2021 update on diagnosis, risk-stratification, and management.

Authors:  Alexandra C Hristov; Trilokraj Tejasvi; Ryan A Wilcox
Journal:  Am J Hematol       Date:  2021-08-02       Impact factor: 13.265

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.